# Can Albumin/C-reactive Protein Ratio be Utilized for Predicting Gestational Diabetes Diagnosis or the Adverse Outcomes

> **NCT06761053** · NA · COMPLETED · sponsor: **ALI BAHADIRLI** · enrollment: 146 (actual)

## Conditions studied

- Gestational Diabetes Mellitus in Pregnancy

## Interventions

- **DIAGNOSTIC_TEST:** Intervention/Exposure for the GDM Group (Experimental Arm)
- **DIAGNOSTIC_TEST:** Intervention/Exposure for the Control Group

## Key facts

- **NCT ID:** NCT06761053
- **Lead sponsor:** ALI BAHADIRLI
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-03
- **Primary completion:** 2022-02-03
- **Final completion:** 2022-07-03
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2025-01-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06761053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06761053, "Can Albumin/C-reactive Protein Ratio be Utilized for Predicting Gestational Diabetes Diagnosis or the Adverse Outcomes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06761053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*